Log in

SHRX Sharp Therapeutics Corp. TSXV · United States

Sharp Therapeutics (SHRX) news

Sharp Therapeutics Corp. is a public biotech or pharmaceutical company listed on TSXV under the ticker SHRX, recorded under United States. The directory classifies it as Small-molecule genetic-disease drug developer. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Sharp Therapeutics news

We have not published a story on Sharp Therapeutics yet. When there is news, it will appear here.

Questions about Sharp Therapeutics

What is the ticker symbol of Sharp Therapeutics?

Sharp Therapeutics Corp. trades under the ticker SHRX on TSXV.

Where is Sharp Therapeutics listed?

Sharp Therapeutics Corp. is listed on TSXV.

Which country or territory is Sharp Therapeutics listed under?

Our directory records Sharp Therapeutics Corp. under United States.

What does Sharp Therapeutics do?

Our directory classifies Sharp Therapeutics Corp. as: Small-molecule genetic-disease drug developer. This is a directory classification, not a description of the pipeline.

What is the ISIN of Sharp Therapeutics?

The ISIN recorded for Sharp Therapeutics Corp. is CA8200092077.

Does aibio.space cover Sharp Therapeutics?

aibio.space lists Sharp Therapeutics Corp. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Sharp Therapeutics?

Companies in our directory listed in the same country and business area as Sharp Therapeutics: Moleculin Biotech, IB Acquisition, Meihua International Medical Technologies Co., OSR Health, ProPhase Labs, NEPHROS INC.

Investor discussion: Sharp Therapeutics

Members talk about Sharp Therapeutics (SHRX). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open TSXV:SHRX on TradingView.

Listing details

Sharp Therapeutics Corp. is a public biotech or pharmaceutical company listed on TSXV under the ticker SHRX, recorded under United States. The directory classifies it as Small-molecule genetic-disease drug developer. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Sharp Therapeutics Corp.
Ticker
SHRX
Listing
TSXV
Country or territory
United States
Business scope
Small-molecule genetic-disease drug developer
ISIN
CA8200092077
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.